Skip to main content

COVID-19 Topic Center

Interactive Features

First Report Managed Care
Sarah Temkin, MD, board-certified gynecologic oncologist, and Don Dizon, MD, oncologist specializing in women’s cancers, discuss an ongoing Phase III trial that examines the use of selinexor for the treatment of endometrial cancer, and highlight what they hope to see for the future of care.…
First Report Managed Care
Saad Usmani, MD, discusses the recent approval of daratumumab subcutaneous formulation for patients with multiple myeloma, and explains the major benefits of this treatment for this patient population.  Podcast Transcript: Julie Gould:  Welcome back to Pop Health Perspectives, a…
First Report Managed Care
In this podcast, Andree Amelsberg, vice president of US Medical Affairs Oncology and Hematology at Janssen, and Danelle James, Imbruvica clinical science lead at Pharmacyclics LLC, an AbbVie company, discuss the recent expanded approval of Imbruvica (ibrutinib) plus rituximab for the treatment of…
Back to Top